Journal of clinical pharmacology
Risks and Benefits for Sirolimus in Aging Prevention.
Mallikaarjun S, Kirstein M N, Gupta A K, Shukla S, Gromme A N, ACCP Public Policy Committee
Published: 202510.1002/jcph.70112
Abstract
There is keen interest amongst the general population in preventing aging and age-related infirmities. Sirolimus is approved for preventing organ rejection in kidney transplant patients, has immune-modulating and growth-inhibitory properties, and is…
Preview only. Read the full abstract at the source